Michael J Gonzalez to Humans
This is a "connection" page, showing publications Michael J Gonzalez has written about Humans.
Connection Strength
0.644
-
Barrett WM, Meyer DE, Smith RL, Takkellapati S, Gonzalez MA. Review of generic scenario environmental release and occupational exposure models used in chemical risk assessment. J Occup Environ Hyg. 2023 11; 20(11):545-562.
Score: 0.043
-
Gonzalez MJ, Kweh MF, Biava PM, Olalde J, Toro AP, Goldschmidt-Clermont PJ, White IA. Evaluation of exosome derivatives as bio-informational reprogramming therapy for cancer. J Transl Med. 2021 03 09; 19(1):103.
Score: 0.036
-
Chan Wah Hak C, Coyle C, Kocache A, Short D, Sarwar N, Seckl MJ, Gonzalez MA. Emergency Etoposide-Cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN). BMC Cancer. 2019 Aug 05; 19(1):770.
Score: 0.032
-
Gonz?lez MJ, Miranda-Massari JR, Duconge J, Allende-Vigo MZ, Jim?nez-Ram?rez FJ, Cintr?n K, Rodr?guez-G?mez JR, Rosario G, Ricart C, Santiago-Cornier JA, Zaragoza-Urdaz R, V?zquez A, Hickey S, Jabbar-Berdiel M, Riordan N, Ichim T, Santiago O, Alvarado G, Vora P. Metabolic correction: a functional biochemical mechanism against disease--Part 1: concept and historical background. P R Health Sci J. 2015 Mar; 34(1):3-8.
Score: 0.024
-
Gonzalez MJ, Miranda-Massari JR. Diet and stress. Psychiatr Clin North Am. 2014 Dec; 37(4):579-89.
Score: 0.023
-
Gonzalez MA, Feely SM, Speziani F, Strickland AV, Danzi M, Bacon C, Lee Y, Chou TF, Blanton SH, Weihl CC, Zuchner S, Shy ME. A novel mutation in VCP causes Charcot-Marie-Tooth Type 2 disease. Brain. 2014 Nov; 137(Pt 11):2897-902.
Score: 0.023
-
Gonz?lez AM, Cruz SY, R?os JL, Pag?n I, Fabi?n C, Betancourt J, Rivera-Soto WT, Gonz?lez MJ, Palacios C. Alcohol consumption and smoking and their associations with socio-demographic characteristics, dietary patterns, and perceived academic stress in Puerto Rican college students. P R Health Sci J. 2013 Jun; 32(2):82-8.
Score: 0.021
-
Gonzalez MA, Lebrigio RF, Van Booven D, Ulloa RH, Powell E, Speziani F, Tekin M, Sch?le R, Z?chner S. GEnomes Management Application (GEM.app): a new software tool for large-scale collaborative genome analysis. Hum Mutat. 2013 Jun; 34(6):842-6.
Score: 0.021
-
Gonzalez MJ, Miranda Massari JR, Duconge J, Riordan NH, Ichim T, Quintero-Del-Rio AI, Ortiz N. The bio-energetic theory of carcinogenesis. Med Hypotheses. 2012 Oct; 79(4):433-9.
Score: 0.020
-
Gonz?lez MJ, Miranda-Massari JR, Duconge J. Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later: comment on the article by Cabanillas. P R Health Sci J. 2010 Dec; 29(4):410-1; author reply 411-2.
Score: 0.018
-
Gonzalez MJ, Miranda-Massari JR. Advances in vitamin C research. Integr Cancer Ther. 2006 Mar; 5(1):7-8.
Score: 0.013
-
Gonz?lez MJ, Herrera FL, Miranda-Massari JM, Guzm?n AM, Riordan NH, Ricart CM. Tumor growth parameters of in-vivo human breast carcinoma: a proposed mathematical model for tumor growth kinetics. P R Health Sci J. 2006 Mar; 25(1):71-3.
Score: 0.013
-
Gonz?lez MJ, Miranda-Massari JR, Mora EM, Guzm?n A, Riordan NH, Riordan HD, Casciari JJ, Jackson JA, Rom?n-Franco A. Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integr Cancer Ther. 2005 Mar; 4(1):32-44.
Score: 0.012
-
Gonzalez MA, Tachibana KE, Laskey RA, Coleman N. Control of DNA replication and its potential clinical exploitation. Nat Rev Cancer. 2005 02; 5(2):135-41.
Score: 0.012
-
Gonzalez MA, Tachibana KE, Chin SF, Callagy G, Madine MA, Vowler SL, Pinder SE, Laskey RA, Coleman N. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J Pathol. 2004 Oct; 204(2):121-30.
Score: 0.012
-
Mikirova N, Riordan HD, Jackson JA, Wong K, Miranda-Massari JR, Gonzalez MJ. Erythrocyte membrane fatty acid composition in cancer patients. P R Health Sci J. 2004 Jun; 23(2):107-13.
Score: 0.011
-
Gonz?lez MJ, Ricart CM, Miranda-Massari J. A vitamin, mineral, herb dietary supplement effect on blood glucose in uncontrolled type II diabetic subjects. P R Health Sci J. 2004 Jun; 23(2):119-20.
Score: 0.011
-
Gonz?lez MJ, Miranda-Massari JR, Ricart CM. Effect of a dietary supplement combination on weight management, adipose tissue, cholesterol and triglycerides in obese subjects. P R Health Sci J. 2004 Jun; 23(2):121-4.
Score: 0.011
-
Chea JD, Ruiz-Mercado GJ, Smith RL, Meyer DE, Gonzalez MA, Barrett WM. Material Flow Analysis and Occupational Exposure Assessment in Additive Manufacturing End-of-Life Material Management. Environ Sci Technol. 2024 May 21; 58(20):9000-9012.
Score: 0.011
-
Gonzalez MA, Pinder SE, Callagy G, Vowler SL, Morris LS, Bird K, Bell JA, Laskey RA, Coleman N. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J Clin Oncol. 2003 Dec 01; 21(23):4306-13.
Score: 0.011
-
Ruiz A, Luebke J, Moore K, Vann AD, Gonzalez M, Ochoa-Nordstrum B, Barbon R, Gondwe K, Mkandawire-Valhmu L. The impact of the COVID-19 pandemic on help-seeking behaviours of Indigenous and Black women experiencing intimate partner violence in the United States. J Adv Nurs. 2023 Jul; 79(7):2470-2483.
Score: 0.010
-
Gonz?lez MJ, Mora EM, Miranda-Massari JR, Matta J, Riordan HD, Riordan NH. Inhibition of human breast carcinoma cell proliferation by ascorbate and copper. P R Health Sci J. 2002 Mar; 21(1):21-3.
Score: 0.010
-
Gonz?lez MJ, Miranda-Massari JR, Mora EM, Jim?nez IZ, Matos MI, Riordan HD, Casciari JJ, Riordan NH, Rodr?guez M, Guzm?n A. Orthomolecular oncology: a mechanistic view of intravenous ascorbate's chemotherapeutic activity. P R Health Sci J. 2002 Mar; 21(1):39-41.
Score: 0.010
-
Gonz?lez MJ, Miranda-Massari JR, Mora EM, Cruzado NA, Jim?nez I, Rosa M, Matos Vera MI, Santiago C, Rom?n-Eyxarch MI, Rodr?guez JR, P?rez Cort?s C, Riordan NH, Riordan HD, Ricart CM. Integrative medicine: a paradigm shift in medical education and practice. P R Health Sci J. 2000 Dec; 19(4):389-92.
Score: 0.009
-
Gonz?lez L, Nazario CM, Gonz?lez MJ. Nutrition-related problems of pediatric patients with neuromuscular disorders. P R Health Sci J. 2000 Mar; 19(1):35-8.
Score: 0.008
-
Wu C, Devkota B, Evans P, Zhao X, Baker SW, Niazi R, Cao K, Gonzalez MA, Jayaraman P, Conlin LK, Krock BL, Deardorff MA, Spinner NB, Krantz ID, Santani AB, Tayoun ANA, Sarmady M. Rapid and accurate interpretation of clinical exomes using Phenoxome: a computational phenotype-driven approach. Eur J Hum Genet. 2019 04; 27(4):612-620.
Score: 0.008
-
Gonz?lez MJ, Schmitz KJ, Matos MI, L?pez D, Rodr?guez JR, Gorr?n JJ. Folate supplementation and neural tube defects: a review of a public health issue. P R Health Sci J. 1997 Dec; 16(4):387-93.
Score: 0.007
-
Gonz?lez MJ, Nazario CM. The effect of ascorbic acid on human T cells. P R Health Sci J. 1996 Dec; 15(4):309-10.
Score: 0.007
-
Horga A, Tomaselli PJ, Gonzalez MA, Laur? M, Muntoni F, Manzur AY, Hanna MG, Blake JC, Houlden H, Z?chner S, Reilly MM. SIGMAR1 mutation associated with autosomal recessive Silver-like syndrome. Neurology. 2016 Oct 11; 87(15):1607-1612.
Score: 0.007
-
Pottier C, Ravenscroft TA, Brown PH, Finch NA, Baker M, Parsons M, Asmann YW, Ren Y, Christopher E, Levitch D, van Blitterswijk M, Cruchaga C, Campion D, Nicolas G, Richard AC, Guerreiro R, Bras JT, Zuchner S, Gonzalez MA, Bu G, Younkin S, Knopman DS, Josephs KA, Parisi JE, Petersen RC, Ertekin-Taner N, Graff-Radford NR, Boeve BF, Dickson DW, Rademakers R. TYROBP genetic variants in early-onset Alzheimer's disease. Neurobiol Aging. 2016 12; 48:222.e9-222.e15.
Score: 0.007
-
Gonz?lez MJ, Riordan NH. The paradoxical role of lipid peroxidation on carcinogenesis and tumor growth: a commentary. Med Hypotheses. 1996 Jun; 46(6):503-4.
Score: 0.007
-
Vaddula BR, Tantak MP, Sadana R, Gonzalez MA, Kumar D. One-pot synthesis and in-vitro anticancer evaluation of 5-(2'-indolyl)thiazoles. Sci Rep. 2016 Mar 29; 6:23401.
Score: 0.006
-
Balicza P, Grosz Z, Gonzalez MA, Bencsik R, Pentelenyi K, Gal A, Varga E, Klivenyi P, Koller J, Z?chner S, Molnar JM. Genetic background of the hereditary spastic paraplegia phenotypes in Hungary - An analysis of 58 probands. J Neurol Sci. 2016 May 15; 364:116-21.
Score: 0.006
-
Abrams AJ, Hufnagel RB, Rebelo A, Zanna C, Patel N, Gonzalez MA, Campeanu IJ, Griffin LB, Groenewald S, Strickland AV, Tao F, Speziani F, Abreu L, Sch?le R, Caporali L, La Morgia C, Maresca A, Liguori R, Lodi R, Ahmed ZM, Sund KL, Wang X, Krueger LA, Peng Y, Prada CE, Prows CA, Schorry EK, Antonellis A, Zimmerman HH, Abdul-Rahman OA, Yang Y, Downes SM, Prince J, Fontanesi F, Barrientos A, N?meth AH, Carelli V, Huang T, Zuchner S, Dallman JE. Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder. Nat Genet. 2015 Aug; 47(8):926-32.
Score: 0.006
-
Strickland AV, Schabh?ttl M, Offenbacher H, Synofzik M, Hauser NS, Brunner-Krainz M, Gruber-Sedlmayr U, Moore SA, Windhager R, Bender B, Harms M, Klebe S, Young P, Kennerson M, Garcia AS, Gonzalez MA, Z?chner S, Schule R, Shy ME, Auer-Grumbach M. Mutation screen reveals novel variants and expands the phenotypes associated with DYNC1H1. J Neurol. 2015 Sep; 262(9):2124-34.
Score: 0.006
-
Goodson WH, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK, Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, Zhou BP, Blanco-Aparicio C, Baglole CJ, Dong C, Mondello C, Hsu CW, Naus CC, Yedjou C, Curran CS, Laird DW, Koch DC, Carlin DJ, Felsher DW, Roy D, Brown DG, Ratovitski E, Ryan EP, Corsini E, Rojas E, Moon EY, Laconi E, Marongiu F, Al-Mulla F, Chiaradonna F, Darroudi F, Martin FL, Van Schooten FJ, Goldberg GS, Wagemaker G, Nangami GN, Calaf GM, Williams G, Wolf GT, Koppen G, Brunborg G, Lyerly HK, Krishnan H, Ab Hamid H, Yasaei H, Sone H, Kondoh H, Salem HK, Hsu HY, Park HH, Koturbash I, Miousse IR, Scovassi AI, Klaunig JE, Vondr?cek J, Raju J, Roman J, Wise JP, Whitfield JR, Woodrick J, Christopher JA, Ochieng J, Martinez-Leal JF, Weisz J, Kravchenko J, Sun J, Prudhomme KR, Narayanan KB, Cohen-Solal KA, Moorwood K, Gonzalez L, Soucek L, Jian L, D'Abronzo LS, Lin LT, Li L, Gulliver L, McCawley LJ, Memeo L, Vermeulen L, Leyns L, Zhang L, Valverde M, Khatami M, Romano MF, Chapellier M, Williams MA, Wade M, Manjili MH, Lleonart ME, Xia M, Gonzalez MJ, Karamouzis MV, Kirsch-Volders M, Vaccari M, Kuemmerle NB, Singh N, Cruickshanks N, Kleinstreuer N, van Larebeke N, Ahmed N, Ogunkua O, Krishnakumar PK, Vadgama P, Marignani PA, Ghosh PM, Ostrosky-Wegman P, Thompson PA, Dent P, Heneberg P, Darbre P, Sing Leung P, Nangia-Makker P, Cheng QS, Robey RB, Al-Temaimi R, Roy R, Andrade-Vieira R, Sinha RK, Mehta R, Vento R, Di Fiore R, Ponce-Cusi R, Dornetshuber-Fleiss R, Nahta R, Castellino RC, Palorini R, Abd Hamid R, Langie SA, Eltom SE, Brooks SA, Ryeom S, Wise SS, Bay SN, Harris SA, Papagerakis S, Romano S, Pavanello S, Eriksson S, Forte S, Casey SC, Luanpitpong S, Lee TJ, Otsuki T, Chen T, Massfelder T, Sanderson T, Guarnieri T, Hultman T, Dormoy V, Odero-Marah V, Sabbisetti V, Maguer-Satta V, Rathmell WK, Engstr?m W, Decker WK, Bisson WH, Rojanasakul Y, Luqmani Y, Chen Z, Hu Z. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis. 2015 Jun; 36 Suppl 1:S254-96.
Score: 0.006
-
Miranda-Massari JR, Gonzalez MJ, Fernando AS, Cidre C, Paz IM, Charvel J, Mart?nez V, Duconge J, Aponte A, Ricart CM. Metabolic Correction as a tool to improve diabetes type 2 management. Bol Asoc Med P R. 2015 Apr-Jun; 107(2):54-9.
Score: 0.006
-
Miranda-Massari JR, Gonz?lez MJ, Rodriguez-Gomez JR, Duconge J, Allende-Vigo MZ, Jim?nez Ramirez FJ, Cintr?n K, Ricart C, Zaragoza-Urdaz R, Berdiel MJ, V?zquez A. [Metabolic correction: a biochemical option against diseases]. Bol Asoc Med P R. 2015 Apr-Jun; 107(2):60-6.
Score: 0.006
-
Miranda-Massari JR, Gonz?lez MJ, Duconge J, Allende-Vigo MZ, Jim?nez-Ram?rez FJ, Hickey S, V?zquez A, Berdiel MJ, Cintr?n K, Rodr?guez-G?mez JR. Metabolic correction: a functional biochemical mechanism against disease--Part 2: mechanisms and benefits. P R Health Sci J. 2015 Mar; 34(1):9-13.
Score: 0.006
-
Petersmark K, Rodr?guez JR, Matos MI, Gonz?lez MJ. Regional differences in fat cell lipolytic mechanisms: a critical review. P R Health Sci J. 1995 Mar; 14(1):11-6.
Score: 0.006
-
Griffin LB, Sakaguchi R, McGuigan D, Gonzalez MA, Searby C, Z?chner S, Hou YM, Antonellis A. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations. Hum Mutat. 2014 Nov; 35(11):1363-71.
Score: 0.006
-
Bonifert T, Karle KN, Tonagel F, Batra M, Wilhelm C, Theurer Y, Schoenfeld C, Kluba T, Kamenisch Y, Carelli V, Wolf J, Gonzalez MA, Speziani F, Sch?le R, Z?chner S, Sch?ls L, Wissinger B, Synofzik M. Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier. Brain. 2014 Aug; 137(Pt 8):2164-77.
Score: 0.006
-
Caballero Oteyza A, Battaloglu E, Ocek L, Lindig T, Reichbauer J, Rebelo AP, Gonzalez MA, Zorlu Y, Ozes B, Timmann D, Bender B, Woehlke G, Z?chner S, Sch?ls L, Sch?le R. Motor protein mutations cause a new form of hereditary spastic paraplegia. Neurology. 2014 Jun 03; 82(22):2007-16.
Score: 0.006
-
Dolzhanskaya N, Gonzalez MA, Sperziani F, Stefl S, Messing J, Wen GY, Alexov E, Zuchner S, Velinov M. A novel p.Leu(381)Phe mutation in presenilin 1 is associated with very early onset and unusually fast progressing dementia as well as lysosomal inclusions typically seen in Kufs disease. J Alzheimers Dis. 2014; 39(1):23-7.
Score: 0.006
-
Gonz?lez MJ, Herrera FL. Cell loss and tumor growth revisited. Med Hypotheses. 1994 Jan; 42(1):39-42.
Score: 0.006
-
Foley AR, Menezes MP, Pandraud A, Gonzalez MA, Al-Odaib A, Abrams AJ, Sugano K, Yonezawa A, Manzur AY, Burns J, Hughes I, McCullagh BG, Jungbluth H, Lim MJ, Lin JP, Megarbane A, Urtizberea JA, Shah AH, Antony J, Webster R, Broomfield A, Ng J, Mathew AA, O'Byrne JJ, Forman E, Scoto M, Prasad M, O'Brien K, Olpin S, Oppenheim M, Hargreaves I, Land JM, Wang MX, Carpenter K, Horvath R, Straub V, Lek M, Gold W, Farrell MO, Brandner S, Phadke R, Matsubara K, McGarvey ML, Scherer SS, Baxter PS, King MD, Clayton P, Rahman S, Reilly MM, Ouvrier RA, Christodoulou J, Z?chner S, Muntoni F, Houlden H. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain. 2014 Jan; 137(Pt 1):44-56.
Score: 0.005
-
Mateo J, Ong M, Tan DS, Gonzalez MA, de Bono JS. Appraising iniparib, the PARP inhibitor that never was--what must we learn? Nat Rev Clin Oncol. 2013 Dec; 10(12):688-96.
Score: 0.005
-
Gonzalez MJ, Schemmel RA, Dugan L, Gray JI, Welsch CW. Dietary fish oil inhibits human breast carcinoma growth: a function of increased lipid peroxidation. Lipids. 1993 Sep; 28(9):827-32.
Score: 0.005
-
Betancourt J, R?os JL, Pag?n I, Fabi?n C, Gonz?lez AM, Cruz SY, Gonz?lez MJ, Rivera WT, Palacios C. Non-medical use of prescription drugs and its association with socio-demographic characteristics, dietary pattern, and perceived academic load and stress in college students in Puerto Rico. P R Health Sci J. 2013 Jun; 32(2):89-94.
Score: 0.005
-
R?os JL, Betancourt J, Pag?n I, Fabi?n C, Cruz SY, Gonz?lez AM, Gonz?lez MJ, Rivera-Soto WT, Palacios C. Caffeinated-beverage consumption and its association with socio-demographic characteristics and self-perceived academic stress in first and second year students at the University of Puerto Rico Medical Sciences Campus (UPR-MSC). P R Health Sci J. 2013 Jun; 32(2):95-100.
Score: 0.005
-
Fabi?n C, Pag?n I, R?os JL, Betancourt J, Cruz SY, Gonz?lez AM, Palacios C, Gonz?lez MJ, Rivera-Soto WT. Dietary patterns and their association with sociodemographic characteristics and perceived academic stress of college students in Puerto Rico. P R Health Sci J. 2013 Mar; 32(1):36-43.
Score: 0.005
-
Cruz SY, Fabi?n C, Pag?n I, R?os JL, Gonz?lez AM, Betancourt J, Gonz?lez MJ, Rivera-Soto WT, Palacios C. Physical activity and its associations with sociodemographic characteristics, dietary patterns, and perceived academic stress in students attending college in Puerto Rico. P R Health Sci J. 2013 Mar; 32(1):44-50.
Score: 0.005
-
Martin E, Sch?le R, Smets K, Rastetter A, Boukhris A, Loureiro JL, Gonzalez MA, Mundwiller E, Deconinck T, Wessner M, Jornea L, Oteyza AC, Durr A, Martin JJ, Sch?ls L, Mhiri C, Lamari F, Z?chner S, De Jonghe P, Kabashi E, Brice A, Stevanin G. Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia. Am J Hum Genet. 2013 Feb 07; 92(2):238-44.
Score: 0.005
-
Gonzalez MJ. Lipid peroxidation and tumor growth: an inverse relationship. Med Hypotheses. 1992 Jun; 38(2):106-10.
Score: 0.005
-
Miranda-Massari JR, Gonzalez MJ, Jimenez FJ, Allende-Vigo MZ, Duconge J. Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control. Curr Clin Pharmacol. 2011 Nov; 6(4):260-73.
Score: 0.005
-
Gonzalez MJ, Schemmel RA, Gray JI, Dugan L, Sheffield LG, Welsch CW. Effect of dietary fat on growth of MCF-7 and MDA-MB231 human breast carcinomas in athymic nude mice: relationship between carcinoma growth and lipid peroxidation product levels. Carcinogenesis. 1991 Jul; 12(7):1231-5.
Score: 0.005
-
Gonz?lez MJ, Rodr?guez JR. Fat and breast cancer: a mini-review of experimental data on rodents. Bol Asoc Med P R. 1991 Jun; 83(6):264-6.
Score: 0.005
-
Ichim TE, Minev B, Braciak T, Luna B, Hunninghake R, Mikirova NA, Jackson JA, Gonzalez MJ, Miranda-Massari JR, Alexandrescu DT, Dasanu CA, Bogin V, Ancans J, Stevens RB, Markosian B, Koropatnick J, Chen CS, Riordan NH. Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med. 2011 Mar 04; 9:25.
Score: 0.005
-
Gonzalez MJ. Serum concentrations and cellular uptake of vitamin E. Med Hypotheses. 1990 Jun; 32(2):107-10.
Score: 0.004
-
Duconge J, Miranda-Massari JR, Gonzalez MJ, Jackson JA, Warnock W, Riordan NH. Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate. P R Health Sci J. 2008 Mar; 27(1):7-19.
Score: 0.004
-
Duconge J, Miranda-Massari JR, Gonz?lez MJ, Taylor PR, Riordan HD, Riordan NH, Casciari JJ, Alliston K. Vitamin C pharmacokinetics after continuous infusion in a patient with prostate cancer. Ann Pharmacother. 2007 Jun; 41(6):1082-3.
Score: 0.003
-
Riordan HD, Casciari JJ, Gonz?lez MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA. A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. P R Health Sci J. 2005 Dec; 24(4):269-76.
Score: 0.003
-
Meng X, Riordan NH, Riordan HD, Mikirova N, Jackson J, Gonz?lez MJ, Miranda-Massari JR, Mora E, Trinidad Castillo W. Cell membrane fatty acid composition differs between normal and malignant cell lines. P R Health Sci J. 2004 Jun; 23(2):103-6.
Score: 0.003
-
Riordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, Gonz?lez MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A. Intravenous vitamin C as a chemotherapy agent: a report on clinical cases. P R Health Sci J. 2004 Jun; 23(2):115-8.
Score: 0.003
-
Riordan HD, Hunninghake RB, Riordan NH, Jackson JJ, Meng X, Taylor P, Casciari JJ, Gonz?lez MJ, Miranda-Massari JR, Mora EM, Rosario N, Rivera A. Intravenous ascorbic acid: protocol for its application and use. P R Health Sci J. 2003 Sep; 22(3):287-90.
Score: 0.003
-
Santiago E, Gonz?lez MJ, Matos MI, P?rez CM. Association between dietary fat and breast cancer in Puerto Rican postmenopausal women attending a breast cancer clinic. P R Health Sci J. 1998 Sep; 17(3):235-41.
Score: 0.002
-
Santiago E, Gonz?lez MJ, Matos MI, P?rez CM. Dietary fat and breast cancer: a brief update on current knowledge. P R Health Sci J. 1998 Sep; 17(3):273-9.
Score: 0.002